Advertisement
Wednesday, Dec 01, 2021
Outlook.com
Outlook.com

FDA Authorises Extra COVID Vaccines For Those With Weak Immunities

The announcement came on Thursday, by the Food and Drug Administration which applies to several million Americans who are especially vulnerable because of organ transplants, certain cancers, or other disorders.

FDA Authorises Extra COVID Vaccines For Those With Weak Immunities
Extra dose of Pfizer Or Moderna approved for those with weakend immunities | File photo
FDA Authorises Extra COVID Vaccines For Those With Weak Immunities
outlookindia.com
2021-08-13T10:20:08+05:30

U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.

The late-night announcement on Thursday by the Food and Drug Administration applies to several million Americans who are especially vulnerable because of organ transplants, certain cancers, or other disorders. Several other countries, including France and Israel, have similar recommendations.

It’s harder for vaccines to rev up an immune system suppressed by certain medications and diseases, so those patients don’t always get the same protection as otherwise healthy people — and small studies suggest for at least some, an extra dose may be the solution.

“Today’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19,” Dr. Janet Woodcock, the FDA’s acting commissioner, said in a statement.

The FDA determined that transplant recipients and others with a similar level of compromised immunity can receive a third dose of the vaccines from Pfizer and Moderna at least 28 days after getting their second shot. The FDA made no mention of immune-compromised patients who received the single-dose Johnson & Johnson vaccine.

The announcement comes as the extra-contagious delta version of the coronavirus surges through much of the country, pushing new cases, hospitalizations, and deaths to heights not seen since last winter.

Importantly, the FDA’s decision only applies to this high-risk group, estimated to be no more than 3% of U.S. adults. It’s not an opening for booster doses for the general population.

Instead, health authorities consider the extra dose part of the initial prescription for the immune-compromised. For example, France since April has encouraged that such patients get the third dose four weeks after their regular second shot. Israel and Germany also recently began recommending a third dose of two-dose vaccines.

Separately, U.S. health officials are continuing to closely monitor if and when average people’s immunity wanes enough to require boosters for everyone — but for now, the vaccines continue to offer robust protection for the general population.

The Centers for Disease Control and Prevention is expected to formally recommend the extra shots for certain immune-compromised groups after a meeting Friday of its outside advisers.

Transplant recipients and others with suppressed immune systems know they’re at more risk than the average American and some have been seeking out extra doses on their own, even if it means lying about their vaccination status. The change means now the high-risk groups can more easily get another shot — but experts caution it’s not yet clear exactly who should.


“This is all going to be very personalized,” cautioned Dr. Dorry Segev, a transplant surgeon at Johns Hopkins University who is running a major National Institutes of Health study of extra shots for organ recipients. For some people, a third dose “increases their immune response. Yet for some people, it does not seem to. We don’t quite know who’s who yet.”

One recent study of more than 650 transplant recipients found just over half harbored virus-fighting antibodies after two doses of the Pfizer or Moderna vaccines — although generally less than in otherwise healthy vaccinated people. Another study of people with rheumatoid arthritis and similar autoimmune diseases found only those who use particular medications have very poor vaccine responses.

There’s little data on how well a third dose works, and if it causes any safety problems such as an increased risk of organ rejection. Wednesday, Canadian researchers reported that transplant recipients were more likely to have high levels of antibodies if they got the third dose than those given a dummy shot for comparison. Other small studies have similarly found that some transplant recipients respond to a third dose while others still lack enough protection.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

PM Modi’s Meeting With Vladimir Putin Likely To Reaffirm Indo-Russia Links

PM Modi’s Meeting With Vladimir Putin Likely To Reaffirm Indo-Russia Links

Though Narendra Modi’s foreign policy is seen as tilting towards the US, he is aware of the importance of Russia and the need to maintain the special and privileged strategic partnership with Moscow.

Omicron Scare: All You Need To Know About India's New Travel Rules Effective From Today

Omicron Scare: All You Need To Know About India's New Travel Rules Effective From Today

Health Ministry has separated travelers coming from Omicron Variant 'Countries at-risk' from other international travelers. Check the list here, along with other guidelines.

SL Vs WI, 2nd Test, Live: Brathwaite's Fifty Leads West Indies

SL Vs WI, 2nd Test, Live: Brathwaite's Fifty Leads West Indies

Follow live cricket scores of Day 3 of the second Test between Sri Lanka vs West Indies in Galle. West Indies are replying to Sri Lanka's first innings score of 204 all out in a rain-hit contest.

Kashmir: Why Is BJP Predicting Doomsday For J&K 2 Years After Article 370 Abrogation

Kashmir: Why Is BJP Predicting Doomsday For J&K 2 Years After Article 370 Abrogation

The statement, issued by senior BJP leader of J&K Ashwani Kumar Chrungoo, raises concern for minorities living in Kashmir Valley.

Advertisement